Document is current
Any future updates will be listed below
-
Authors
Gofton, Cameron
Bartolomeo, Anna Di
Wijekulasuriya, Shalini
Cai, Shenghan
Boutros, Rose
Stafford-Bell, Fiona
Caldwell, Kim
McCaughan, Geoffrey
Zekry, Amany
Strasser, Simone I
Levy, Miriam
Sheehan, Caitlin
Goodall, Stephen
Davis, Jan Maree
Sheahan, Linda
Liu, Ken
Greenaway, Sally
Davison, Scott
Huynh, Thang Du
Quadri, Zujaj
Zurynski, Yvonne A
Agar, Meera
George, Jacob
-
Funding
Funding for this research was provided by:
Cancer Institute NSW (2021/ATRG2028, 2021/ATRG2028, 2021/ATRG2028)
University of Sydney
- License Information
-
More Information
Article History
Received: 25 October 2024
Accepted: 24 March 2025
First Online: 16 April 2025
Declarations
:
: JG is on Advisory Boards and has received honoraria for talks from Novo Nordisk, Astra Zeneca, Roche, BMS, Pfizer, Cincera, Pharmaxis, Boehringer Mannheim. SIS is on Advisory Boards and has received honoraria from Novo Nordisk, Astra Zeneca, Roche, Chiesi, Dr Falk Pharma, Abbott Diagnostics, CSL Behring, Sirtex, Eisai. This study was supported through Cancer Institute NSW grant funding (2021/ATRGF2028). JG is supported by the Robert W. Storr Bequest to the Sydney Medical Foundation, University of Sydney; a National Health and Medical Research Council of Australia (NHMRC) Program Grant (GNT1053206), Project, Ideas and Investigator grants (GNT2001692, GNT1107178, GNT1108422, GNT1196492 and GNT2032407) and a Cancer Institute, NSW grant (2021/ATRG2028).
